Literature DB >> 28101325

Role of psilocybin in the treatment of depression.

Ananya Mahapatra1, Rishi Gupta2.   

Abstract

Psilocybin is a naturally occurring alkaloid, pharmacologically similar to the classic hallucinogen lysergic acid diethylamide (LSD). Although primarily used as a recreational drug or an entheogen in particular cultural settings, recent population based studies have shown that it does not lead to serious physical or mental health problems or dependent use. In view of recent work demonstrating psilocybin's potential to increase subjective sense of wellbeing and because of its novel mechanism of 5-HT2A serotonin receptor agonism, it is being explored for possible therapeutic utility in mood and anxiety disorders.

Entities:  

Keywords:  depression; hallucinogen; psilocybin; treatment

Year:  2016        PMID: 28101325      PMCID: PMC5228719          DOI: 10.1177/2045125316676092

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  19 in total

Review 1.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.

Authors:  Franz X Vollenweider; Michael Kometer
Journal:  Nat Rev Neurosci       Date:  2010-08-18       Impact factor: 34.870

2.  Stuck in a rut: rethinking depression and its treatment.

Authors:  Paul E Holtzheimer; Helen S Mayberg
Journal:  Trends Neurosci       Date:  2010-11-08       Impact factor: 13.837

3.  Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

Authors:  Javier González-Maeso; Noelia V Weisstaub; Mingming Zhou; Pokman Chan; Lidija Ivic; Rosalind Ang; Alena Lira; Maria Bradley-Moore; Yongchao Ge; Qiang Zhou; Stuart C Sealfon; Jay A Gingrich
Journal:  Neuron       Date:  2007-02-01       Impact factor: 17.173

4.  Psychedelics not linked to mental health problems or suicidal behavior: a population study.

Authors:  Pål-Ørjan Johansen; Teri Suzanne Krebs
Journal:  J Psychopharmacol       Date:  2015-03-05       Impact factor: 4.153

Review 5.  Psilocybin--summary of knowledge and new perspectives.

Authors:  Filip Tylš; Tomáš Páleníček; Jiří Horáček
Journal:  Eur Neuropsychopharmacol       Date:  2013-12-17       Impact factor: 4.600

6.  Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.

Authors:  Rainer Kraehenmann; Katrin H Preller; Milan Scheidegger; Thomas Pokorny; Oliver G Bosch; Erich Seifritz; Franz X Vollenweider
Journal:  Biol Psychiatry       Date:  2014-04-26       Impact factor: 13.382

7.  Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.

Authors:  Erich Studerus; Michael Kometer; Felix Hasler; Franz X Vollenweider
Journal:  J Psychopharmacol       Date:  2010-09-20       Impact factor: 4.153

8.  Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Authors:  Robin L Carhart-Harris; David Erritzoe; Tim Williams; James M Stone; Laurence J Reed; Alessandro Colasanti; Robin J Tyacke; Robert Leech; Andrea L Malizia; Kevin Murphy; Peter Hobden; John Evans; Amanda Feilding; Richard G Wise; David J Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

9.  Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.

Authors:  Robin L Carhart-Harris; Mark Bolstridge; James Rucker; Camilla M J Day; David Erritzoe; Mendel Kaelen; Michael Bloomfield; James A Rickard; Ben Forbes; Amanda Feilding; David Taylor; Steve Pilling; Valerie H Curran; David J Nutt
Journal:  Lancet Psychiatry       Date:  2016-05-17       Impact factor: 27.083

10.  Psychedelics and mental health: a population study.

Authors:  Teri S Krebs; Pål-Ørjan Johansen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  8 in total

Review 1.  Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.

Authors:  Susan Ling; Felicia Ceban; Leanna M W Lui; Yena Lee; Kayla M Teopiz; Nelson B Rodrigues; Orly Lipsitz; Hartej Gill; Mehala Subramaniapillai; Rodrigo B Mansur; Kangguang Lin; Roger Ho; Joshua D Rosenblat; David Castle; Roger S McIntyre
Journal:  CNS Drugs       Date:  2021-11-17       Impact factor: 5.749

Review 2.  Recent Advances in the Synthesis of Marine-Derived Alkaloids via Enzymatic Reactions.

Authors:  Bi-Shuang Chen; Di Zhang; Fayene Zeferino Ribeiro de Souza; Lan Liu
Journal:  Mar Drugs       Date:  2022-05-30       Impact factor: 6.085

Review 3.  Biosynthesis and synthetic biology of psychoactive natural products.

Authors:  Cooper S Jamieson; Joshua Misa; Yi Tang; John M Billingsley
Journal:  Chem Soc Rev       Date:  2021-06-21       Impact factor: 60.615

Review 4.  Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines.

Authors:  Mervin Chávez-Castillo; Victoria Núñez; Manuel Nava; Ángel Ortega; Milagros Rojas; Valmore Bermúdez; Joselyn Rojas-Quintero
Journal:  Adv Pharmacol Sci       Date:  2019-01-03

5.  Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis.

Authors:  Bach X Tran; Giang H Ha; Giang T Vu; Long H Nguyen; Carl A Latkin; Kalpana Nathan; Roger S McIntyre; Cyrus S Ho; Wilson W Tam; Roger C Ho
Journal:  Int J Environ Res Public Health       Date:  2019-06-26       Impact factor: 3.390

Review 6.  Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Justin Grant; Amza Ali; Lorenzo Gordon; Wilfred Ngwa
Journal:  Molecules       Date:  2022-04-14       Impact factor: 4.927

Review 7.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

Review 8.  Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.

Authors:  Shawn Ziff; Benjamin Stern; Gregory Lewis; Maliha Majeed; Vasavi Rakesh Gorantla
Journal:  Cureus       Date:  2022-02-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.